4 Pharmas With Promising Futures

Big pharma has been accused of having had its day, but Motley Fool Share Advisor senior analyst David Kuo tells TMF managing director Jill Ralph that he can see the light at the end of the tunnel. In this edition, David puts GlaxoSmithKlineAstraZenecaShire, and Hikma through their paces, and explains why he's bullish on each of them.

Investing is by no means easy in today's uncertain economy. That's why we've published "Top Sectors for 2012" -- our guide to three favorable industries. This free report will be dispatched immediately to your inbox. David owns shares in GlaxoSmithKline. Neither he nor Jill own any of the other shares mentioned. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2012 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Read Full Story

Can't get enough business news?

Sign up for Finance Report by AOL and get everything from retailer news to the latest IPOs delivered directly to your inbox daily!

Subscribe to our other newsletters

Emails may offer personalized content or ads. Learn more. You may unsubscribe any time.